Table 2.

Volumetry for the entire cohort and analysis of the subgroups success, failure, and tumor progression

Volumetry	Entire PVO cohort (n = 48)	Treated with radical hepatectomy (n = 27)	Failure to achieve sufficient volume (n = 14)	Tumor progression (n = 7)	p value
sFLR pre-PVO (percent of standardized FLR)	21 ± 5	23 ± 4	17 ± 5	22 ± 5	< 0.05*
FLR pre-PVO (ml)	365 ± 105	415 ± 95	281 ± 77	331 ± 52	< 0.05*
KGR day 1–7 after PVO (%/week)	5.4 ± 4	7 ± 4	4.3 ± 2	2.6 ± 0.8	Ns
KGR between the first and second CT (%/week)	1.5 ± 2	2.2 ± 2	0.1 ± 0.8	2.4 ± 1	0.017*
Increase in ml from PVO to the last evaluation (ml)	156 ± 118	217 ± 123	79 ± 41	77 ± 39	< 0.05* 0.004**
Increase in percent from PVO to the last evaluation (%)	43 ± 30	55 ± 33	31 ± 21	24 ± 13	0.044* 0.043**
sFLR at last volume assessment (percent of standardized FLR)	30 ± 10	35 ± 9	21 ± 5	27 ± 6	< 0.05* 0.043**
Days between PVO and the first CT evaluation	10 ± 8	11 ± 9	9 ± 8	8 ± 3	Ns
Days between the first and second CT evaluation	22 ± 9	23 ± 12	23 ± 6	17 ± 5	Ns

*Comparison of success and failure. **Comparison between success and progress. Data are presented as the mean ± 1 SD